glutathione disulfide has been researched along with Diabetic Angiopathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamblin, M; Hill, MF; Smith, HM | 1 |
| Carlson, EC; Donthi, RV; Epstein, PN; Kralik, PM; Liang, Q; Shen, X | 1 |
2 other study(ies) available for glutathione disulfide and Diabetic Angiopathies
| Article | Year |
|---|---|
Greater propensity of diabetic myocardium for oxidative stress after myocardial infarction is associated with the development of heart failure.
Topics: Animals; Antioxidants; Cardiac Output, Low; Catalase; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Dinoprost; Glutathione Disulfide; Male; Myocardial Infarction; Myocardium; Oxidative Stress; Proteins; Rats; Rats, Sprague-Dawley; Superoxide Dismutase | 2005 |
Overexpression of metallothionein reduces diabetic cardiomyopathy.
Topics: Actins; Animals; Antioxidants; Atrial Natriuretic Factor; Base Sequence; Blood Glucose; Blotting, Northern; Cardiomyopathies; Diabetic Angiopathies; Disease Models, Animal; Gene Expression Regulation; Glutathione Disulfide; Insulin; Metallothionein; Mice; Mice, Transgenic; Molecular Sequence Data; Myocardial Contraction; Oligonucleotide Probes; RNA, Messenger; Transcription, Genetic; Triglycerides | 2002 |